Because ToConceive compensates for a number of male subfertility issues, male infertility patients can correct fertility issues without male genital surgery.
Typically thought of as a woman’s problem, infertility affects four to six million men in the United States each year. According to the American Academy of Family Physicians, one-third of cases of infertility occur because of problems in the man and one-third because of problems in the woman. The remaining one-third of couples dealing with infertility discovers that both the man and woman contribute to the issues.
Numerous factors contribute to male infertility, also known as male subfertility. The most common include anti-sperm antibodies caused by an infection in the prostate, inability to ejaculate, insufficient numbers of sperm and abnormal sperm that prevents fertilization. In 40 percent of men, lifestyle habits and health lead to infertility, according to Conceive Online.
A recent Harvard study found that watching more than 20 hours of television a week lowers sperm counts by 44 percent and getting regular moderate to intense exercise can dramatically increase sperm counts. Changing health habits, including quitting smoking, reducing stress and avoiding heating the testicles, can help offset male subfertility issues. ToConceive, new to the market in 2012 and developed using Nobel Peace Prize-winning technology, is another easy and inexpensive solution to many cases of male subfertility.
ToConceive promotes normal capacitation of the sperm, giving the sperm the ability to swim the six to seven inches through the fallopian tubes to penetrate the ovum for fertilization and conception. Because ToConceive compensates for a number of male subfertility issues, including reduced sperm counts and immature spermatozoa, male infertility patients can correct fertility issues without male genital surgery.
ToConceive also prevents expensive, invasive procedures on the woman, including intra-uterine inseminations and in-vitro fertilization. Facilitating in-vivo sperm capacitation, the natural process where a woman’s conception lubrication capacitates the sperm, ToConceive promotes the natural conception process. Dr. Thompson explains that in-vivo sperm capacitation selects out immature and abnormal sperm that lack capacitation. The process also selects out sperm coated with anti-sperm antibodies or strips off those antibodies to allow for proper capacitation.
“In-vivo sperm capacitation works to allow only the fittest sperm to fertilize, but can only do so with normal vaginal lubrication,” said Dr. Thompson. “ToConceive provides that natural conception lubrication that can alleviate male subfertility and lead to conception.”
No matter whether it is a male or female fertility issue, ToConceive provides hope to couples anxious to conceive.
ToConceive, LLC was established by Dr. Ronald Thompson, OBGYN and inventor of numerous gynecological products and methods. Dr. Thompson holds five United States patents, including fallopian tube method of in-vitro fertilization and embryo transfer, device for retrieval of ovum, embryo transfer arrangement, intrauterine delivery arrangement and in-vitro fertilization procedure using direct vision.
Company Name: ToConceive
Contact Person: Lindsey Elling
Email: Send Email
Address:4030 Mt.Carmel Tobasco Road Suite 327D
Country: United States
iframes are not supported by your browser.